BMPR2 and pulmonary arterial hypertension: The major breakthrough in the mechanism research of PAH is the identification of BMP cascade dysfunction due to BMP receptor 2 (BMPR2) mutations or BMP cascade suppression in hypertensive lungs, which incurred differentiated dPASMCs reentry into a pro-proliferative and anti-apoptotic status 3-4.